Hazard Hub

Product quality Recalls in Canada

347 recalls involving product quality — most are health products recalls. Newest first, updated daily from government open data.

Showing 1–30 of 347

Health Products Type II
2026-11-09

PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)

Product quality

View recall details →

Other
2026-11-03

ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks

Product quality - Packaging

View recall details →

Health Products Type II
2026-10-30

Equate Ultra Strength Antacid Chewable Tablet: may contain foreign matter (metal fragments)

Product quality

View recall details →

Health Products Type I
2026-10-30

Cyclophosphamide for Injection USP: Presence of particulate matter

Product quality

View recall details →

Health Products Type II
2026-10-06

PMS-Carvedilol 25 mg Tablets: Out-of-specification (Impurity)

Product quality

View recall details →

Health Products Type II
2026-10-06

Carvedilol 25 mg Tablets: Out-of-specification (Impurity)

Product quality

View recall details →

Health Products Type II
2026-10-05

PDP-DIPHENHYDRAMINE 25 MG CAPSULE: Out-of-specification (Impurity)

Product quality

View recall details →

Health Products Type II
2026-10-05

Carvedilol 25 mg Tablets: Out-of-specification (Impurity)

Product quality

View recall details →

Health Products Type I
2026-09-25

Limited number of Sarclisa single use vials may have been frozen during shipment

Product quality

View recall details →

Health Products Type II
2026-09-24

Apo-Semaglutide Injection : Incorrect dose display

Product quality

View recall details →

Health Products Type II
2026-09-21

IMAAVY: Affected lots may contain glass particles

Product quality

View recall details →

Other
2026-09-10

Generic acetaminophen by Teva recalled because it may contain foreign material

Contamination - Product quality

View recall details →

Health Products Type II
2026-08-31

JAMP Temozolomide: Out-of-Specification (Assay)

Product quality

View recall details →

Health Products Type II
2026-08-27

Apo-Semaglutide Injection : Incorrect dose display

Product quality

View recall details →

Health Products Type II
2026-08-26

Semaglutide Injection : Out-of-Specification (Impurity)

Product quality

View recall details →

Health Products Type III
2026-08-19

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde may be out of specification in the affected lots.

Product quality

View recall details →

Health Products Type I
2026-08-17

Lactated Ringer's Injection USP: Presence of Particulate Matter

Product quality

View recall details →

Health Products Type III
2026-08-12

Adequan I.M: Presence of particulate matter

Product quality

View recall details →

Health Products Type II
2026-08-05

JAMP Methotrexate 10 mg Tablets: Affected lots may contain oversized tablets.

Product quality

View recall details →

Health Products Type III
2026-07-28

Oxygen 100%: Gas cylinders containing commercial grade oxygen

Product quality

View recall details →

Health Products Type III
2026-07-27

Harmonic Arts Holy Basil Tincture; Out of Specification (total aerobic microbial count)

Product quality

View recall details →

Health Products Type II
2026-07-13

Apo-Tiotropium Capsules; Out-of-specification (particle size)

Product quality

View recall details →

Health Products Type II
2026-07-13

Oribe Serene Scalp Densifying Shampoo; Presence of bacterial contamination

Product quality

View recall details →

Health Products Type II
2026-07-13

BD ChloraPrep™ Clear - 1mL Applicator: Product sterility

Product quality

View recall details →

Other Type I
2026-07-08

Two lots of Omnitrope injectable human growth hormone recalled due to cracked cartridges

Product quality

View recall details →

Health Products Type III
2026-07-06

JAMP Chlorthalidone 12.5 mg tablet: Out of specification (Dissolution)

Product quality

View recall details →

Health Products Type III
2026-07-02

Fludeoxyglucose (18F) Injection; Cracket vial

Product quality

View recall details →

Health Products Type II
2026-06-26

Remifentanil hydrochloride for injection; Out of specification (Assay & Impurity)

Product quality

View recall details →

Health Products Type III
2026-06-25

Spiriva Capsules ; Out-of-specification (uniformity of delivered dose)

Product quality

View recall details →

Health Products Type II
2026-06-17

Polyflex powder for suspension; Cracked vials

Product quality

View recall details →

Other Health Products Hazards

COVID (276)Labelling (71)Contamination (64)Packaging (46)

Browse all recalls by hazard, allergen & year →